Nebbioso, Angela <br/><br/>
Tumor-selective action of HDAC inhibitors involves TRAIL induction in acute myeloid leukemia cells.  [electronic resource] 

 -  Nature medicine  Jan 2005 
 - 77-84 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1078-8956 
<br/><br/><label>Standard No.: </label>10.1038/nm1161  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acute Disease<br/>Apoptosis--drug effects<br/>Apoptosis Regulatory Proteins<br/>Histone Deacetylase Inhibitors<br/>Humans<br/>Leukemia, Myeloid--drug therapy<br/>Membrane Glycoproteins--metabolism<br/>Receptors, Cell Surface--metabolism<br/>TNF-Related Apoptosis-Inducing Ligand<br/>Tumor Necrosis Factor-alpha--metabolism<br/>Tumor Suppressor Protein p53--metabolism